Zobrazeno 1 - 10
of 156
pro vyhledávání: '"William C. DeWolf"'
Autor:
Aria F. Olumi, Roya Khosravi-Far, William C. DeWolf, Towia A. Libermann, Hasan Otu, Xu Huang, Hongmei Yang, Liang Zhang, Xiaoping Zhang
Supplementary Figure 1, and Table 1 from c-Fos as a Proapoptotic Agent in TRAIL-Induced Apoptosis in Prostate Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c1d84087c37f0d07aefecdf898c404
https://doi.org/10.1158/0008-5472.22370960.v1
https://doi.org/10.1158/0008-5472.22370960.v1
Autor:
Ravi Kacker, Mariam Hult, Ignacio F San Francisco, William P Conners, Pablo A Rojas, William C Dewolf, Abraham Morgentaler
Publikováno v:
Asian Journal of Andrology, Vol 18, Iss 1, Pp 16-20 (2016)
This report presents our experience with T therapy in a cohort of T-deficient men on active surveillance (AS) for Gleason 3 + 3 and Gleason 3 + 4 prostate cancer (PCa). A retrospective chart review identified 28 men with T deficiency who underwent T
Externí odkaz:
https://doaj.org/article/56f09da596e245538eab3be74da76c2e
Autor:
Jonathan Wang, William C. DeWolf, M. Eric Hyndman, Trafford Crump, Marcus J. Daniels, Ryan L. Steinberg, Donald L. Lamm, Ashish M. Kamat, Max Kates, Mounica Y. Rao, Kenneth G. Nepple, Nathan A. Brooks, Andrew Vitale, Michael A. O’Donnell, Sarah L. Mott, Trinity J. Bivalacqua, Lewis Thomas, Supriya Nagaraju
Publikováno v:
Journal of Urology. 203:902-909
Rescue intravesical therapies for patients with bacillus Calmette-Guérin failure nonmuscle invasive bladder cancer remain a critical focus of ongoing research. Sequential intravesical gemcitabine and docetaxel therapy has shown safety and efficacy i
Autor:
Trafford Crump, Ryan L. Steinberg, Michael A. O’Donnell, Vignesh T. Packiam, Sarah L. Mott, Max Kates, M. Eric Hyndman, Donald L. Lamm, Ashish M. Kamat, Jonathan Wang, Kenneth G. Nepple, William C. DeWolf, Trinity J. Bivalacqua, L.J. Thomas, Andrew Vitale, Nathan A. Brooks
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 40:9.e1-9.e7
Repeat BCG induction remains an option for select non-muscle invasive bladder cancer (NMIBC) patients who fail initial therapy. Alternative salvage intravesical regimens such as Gemcitabine and Docetaxel (Gem/Doce) have been investigated. We aimed to
Autor:
Lewis Thomas, Michael A. O’Donnell, Marcus J. Daniels, Sarah L. Mott, Ryan L. Steinberg, Mounica Y. Rao, Kenneth G. Nepple, Eric Hyndman, Trafford Crump, Trinity J. Bivalacqua, Jonathan Wang, William C. DeWolf, Nathan A. Brooks, Andrew Vitale, Donald L. Lamm, Ashish M. Kamat, Max Kates, Supriya Nagaraju
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:After the recurrence of NMIBC following BCG therapy, risk stratified management directs patients toward radical cystectomy, clinical trial enrollment, and off-label use o...
Autor:
Liza, Quintana, Ashley, Ward, Sean J, Gerrin, Elizabeth M, Genega, Seymour, Rosen, Martin G, Sanda, Andrew A, Wagner, Peter, Chang, William C, DeWolf, Huihui, Ye
Publikováno v:
Urology. 91:143-149
Objective To compare the utility of saturation core biopsy and 12-core biopsy in detecting true Gleason grades, using final pathology in prostatectomy specimens as outcome measures, with a particular interest in Gleason upgrading. Patients and Method
Publikováno v:
Neurourology and urodynamics. 38(1)
Aims To describe urologic complications in patients with chronically elevated post-void residual (PVR) volumes and to evaluate other related risk factors during a long-term follow-up in patients managed conservatively. Methods Non-neurogenic patients
Publikováno v:
BJU International. 114:229-235
Objective To determine whether total testosterone and free testosterone levels predict disease reclassification in a cohort of men with prostate cancer (PCa) on active surveillance (AS). Patients and Methods Total testosterone and free testosterone c
Autor:
Ivan Pedrosa, Daniel N. Costa, William C. DeWolf, Martin G. Sanda, David F. Yao, B. Nicolas Bloch, Elizabeth M. Genega, Neil M. Rofsky, Long Ngo
Publikováno v:
Magnetic Resonance Imaging. 31:947-952
To establish the value of MRI in targeting re-biopsy for undiagnosed prostate cancer despite multiple negative biopsies and determine clinical relevance of detected tumors.Thirty-eight patients who underwent MRI after 2 or more negative biopsies due